Shuying Yang

1.7k total citations
71 papers, 1.1k citations indexed

About

Shuying Yang is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Shuying Yang has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Shuying Yang's work include Asthma and respiratory diseases (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Shuying Yang is often cited by papers focused on Asthma and respiratory diseases (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Shuying Yang collaborates with scholars based in United Kingdom, United States and China. Shuying Yang's co-authors include Steven Pascoe, Wangsheng Chen, Misba Beerahee, Renard Thomas, Stephen Michielsen, Bobby L. Wilson, Yeon‐Seok Kim, Jaime C. Grunlan, Yuanjian Deng and Xin Wei and has published in prestigious journals such as Macromolecules, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Shuying Yang

67 papers receiving 1.1k citations

Peers

Countries citing papers authored by Shuying Yang

Since Specialization

Citations

This map shows the geographic impact of Shuying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuying Yang more than expected).

Fields of papers citing papers by Shuying Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuying Yang. The network helps show where Shuying Yang may publish in the future.

Co-authorship network of co-authors of Shuying Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuying Yang. A scholar is included among the top collaborators of Shuying Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuying Yang. Shuying Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of INPP5E in Ciliogenesis, Development, and Disease 2024 ·International Journal of Biological Sciences ·(unknown), Shuying Yang	0
2	A simple, cost-effective, and efficient method for screening CRISPR/Cas9 mutants in plants 2024 ·Journal of Plant Physiology ·Yiping Wang, Jun Ma, Yingying Wu, Shuying Yang, Pengxi Wang, Hailei Zhang, (unknown), Lin Chen, (unknown), Yiji Xia, Qiong Wang, Jinglan Liu	1
3	Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia 2024 ·Clinical Pharmacokinetics ·(unknown), Shuying Yang, (unknown), (unknown), Sebastiaan C. Goulooze	2
4	Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials 2023 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Claire Ambery, Shuying Yang, Misba Beerahee, Elodie L. Plan, Mats O. Karlsson	3
5	Inhibition of RIPK1 by ZJU-37 promotes oligodendrocyte progenitor proliferation and remyelination via NF-κB pathway 2022 ·Cell Death Discovery ·(unknown), Shuying Yang, Shuangshuang Zheng, Huanhuan Yan, Huimin Gu, Fan Wang, (unknown), (unknown), (unknown), Yue Wang, Xianhui Meng, (unknown), Hongguang Xia, Jingwei Zhao	17
6	Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients 2022 ·Pharmaceutical Research ·(unknown), Claire Ambery, Shuying Yang, Misba Beerahee, Elodie L. Plan, Mats O. Karlsson	2
7	SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway 2021 ·Frontiers in Pharmacology ·(unknown), Huanhuan Yan, Shuying Yang, Yuhong Zhang, Xiaoyan Xu, Xufeng Cen, Kai Lei, Hongguang Xia	5
8	A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients 2019 ·The AAPS Journal ·Eva Germovsek, Claire Ambery, Shuying Yang, Misba Beerahee, Mats O. Karlsson, Elodie L. Plan	3
9	Sample size for detection of drug effect using item level and total score models for Unified Parkinson's Disease Rating Scale data 2018 ·Journal of Pharmacokinetics and Pharmacodynamics ·Siv Jönsson, Shuying Yang, Chao Chen, Elodie L. Plan, Mats O. Karlsson	1
10	The effect of umeclidinium on lung function and symptoms in patients with fixed airflow obstruction and reversibility to salbutamol: A randomised, 3-phase study 2017 ·Respiratory Medicine ·(unknown), Edward Kerwin, (unknown), Linda Nelsen, Wei Wu, Shuying Yang, Steven Pascoe	10
11	Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD 2017 ·Respiratory Medicine ·Steven Pascoe, (unknown), Joanna Marks-Kończalik, (unknown), Shuying Yang, Pablo Sáez Scherbovsky	15
12	Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome 2016 ·Drugs in R&D ·Shuying Yang, Teodora Pene Dumitrescu	9
13	Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF 2016 ·Thorax ·Paul F. Mercer, Hannah V. Woodcock, Jessica Eley, Manuela Platé, Michal Sulikowski, Pascal F. Durrenberger, Linda A. Franklin, Carmel B. Nanthakumar, Yim Man, Federica Genovese, Robin J. McAnulty, Shuying Yang, Toby M. Maher, Andrew G. Nicholson, Andy Blanchard, Richard P. Marshall, Pauline T. Lukey, Rachel C. Chambers	154
14	Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques 2015 ·Pharmaceutical Research ·Donato Teutonico, Flora T. Musuamba, Hugo Maas, (unknown), Shuying Yang, Meindert Danhof, Oscar Della Pasqua	31
15	A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils 2015 ·Respiratory Medicine ·Joanna Marks-Kończalik, (unknown), (unknown), (unknown), Shuying Yang, Steven Pascoe	19
16	A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome 2015 ·Critical Care Medicine ·Jason D. Christie, Steven N. Vaslef, Philip K.‐Y. Chang, Addison K. May, Scott R. Gunn, Shuying Yang, Kelly Hardes, Lesley Kahl, William Powley, David A. Lipson, Andrew I. Bayliffe, Aili L. Lazaar	29
17	A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma 2014 ·Respiratory Medicine ·Laurie A. Lee, (unknown), Lisa Edwards, Shuying Yang, Steven Pascoe	35
18	Safety Assessment of Ovarian Cryopreservation and Transplantation in Nude Mice Bearing Human Epithelial Ovarian Cancer 2012 ·Asian Pacific Journal of Cancer Prevention ·(unknown), (unknown), Zhaoxin Yang, (unknown), Chunying Chen, (unknown), Lan Hong, (unknown), Shuying Yang	0
19	Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies 2010 ·European Journal of Clinical Pharmacology ·Shuying Yang, Misba Beerahee	11
20	Mid‐p confidence intervals for the poisson expectation 1994 ·Statistics in Medicine ·Geoffrey Cohen, Shuying Yang	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact